CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
Episodes 81-96 of 403
Aiwu Ruth He, MD, PhD
Ghassan K. Abou-Alfa, MD
Aiwu Ruth He, MD, PhD
- MinuteCE®
Pivotal Data Supporting First-Line Durvalumab/Tremelimumab in Unresectable HCC
1.00 program creditGhassan K. Abou-Alfa, MD
Aiwu Ruth He, MD, PhD
Ghassan K. Abou-Alfa, MD
- MinuteCE®
Pivotal Data Supporting First-Line Atezolizumab/Bevacizumab in Unresectable HCC
1.00 program creditAiwu Ruth He, MD, PhD
Ghassan K. Abou-Alfa, MD
Aiwu Ruth He, MD, PhD
- MinuteCE®
Use of ICI Combination Regimens in Patients With Intermediate-Stage HCC
1.00 program creditGhassan K. Abou-Alfa, MD
Leslie Citrome, MD, MPH
Leslie Citrome, MD, MPH
Leslie Citrome, MD, MPH
Leslie Citrome, MD, MPH
Christoph U. Correll, MD
Christoph U. Correll, MD
- MinuteCE®
Practice Changing Highlights in G/GEJ Cancers: The Latest Data from Chicago
1.25 program creditsSamuel J. Klempner, MD
W. Brian Gibler, MD, FACEP, FACC, FAHA
Natalie Kreitzer, MD, MS
Adrian R. Parry-Jones, FRCP, PhD
Hiren C. Patel, PhD, FRCS
David Seiffge, MD
Thorsten Steiner, MD, PhD, MME
Hiren C. Patel, PhD, FRCS
W. Brian Gibler, MD, FACEP, FACC, FAHA
Adrian R. Parry-Jones, FRCP, PhD
Thorsten Steiner, MD, PhD, MME